[Childhood multiple sclerosis and allied demyelinative diseases]

Area of Science:

• Pediatric Neurology
• Neuroimmunology
• Demyelinating Diseases

Background:

• Childhood-onset multiple sclerosis (MS) and allied demyelinating diseases present diagnostic challenges.
• Atypical initial symptoms, including encephalitis or myelitis, can complicate early clinical diagnosis.

Purpose of the Study:

• To highlight the diagnostic difficulties in pediatric MS and allied demyelinating diseases.
• To emphasize the role of ophthalmologic symptoms and neuroimaging in early diagnosis.
• To compare the utility of cerebrospinal fluid (CSF) analysis and MRI in differentiating these conditions.

Main Methods:

• Case series reporting on five pediatric MS and three allied demyelinating disease cases.
• Clinical symptom analysis, including ophthalmologic manifestations.
• Cerebrospinal fluid (CSF) analysis for pleocytosis and oligoclonal IgG bands.
• T2-weighted brain magnetic resonance imaging (MRI) for lesion detection.

Main Results:

• Ophthalmologic symptoms were present in a significant proportion of children with MS and allied demyelinating diseases.
• CSF analysis showed similar findings (pleocytosis, oligoclonal IgG bands) in both MS and other demyelinating disorders, limiting its diagnostic value for MS.
• Neuron-specific enolase (NSE) levels were slightly higher in allied demyelinating diseases compared to MS.
• T2-weighted MRI revealed characteristic white matter lesions in most MS cases, but initial MRI was normal in two cases, indicating its limitations for definitive early diagnosis.

Conclusions:

• Ophthalmologic symptoms in children warrant consideration for MS and allied demyelinating diseases, necessitating brain MRI for differential diagnosis.
• CSF analysis is not sufficiently discriminative for the initial diagnosis of pediatric MS.
• While MRI is crucial, normal initial findings do not exclude MS, underscoring the need for comprehensive diagnostic evaluation.